Latest In Depth


The COVID-19 pandemic doesn't end with a viable vaccine but with a vaccinated population

Added: 19 Nov 2020

With a potential finishing line suddenly appearing over the horizon, getting competitors to the end…

Reviewing EU microbiological safety cabinet regulations

Added: 18 Nov 2020

Following up on the lab management article 'Microbiological safety cabinets - On-site and maintenan…

Embracing change to keep pace with routine test demand

Added: 23 Oct 2020

Penny Pinnock looks at why NHS trusts must work together to meet the challenges facing their labora…

Selecting the right sterile cleanroom clothing solution for compliance with EU GMP Annex I

Added: 23 Oct 2020

Sponsored Content

The new EU GMP Annex I guidelines will require sterile product manufacturers to …

Solving process safety and scale up

Added: 2 Oct 2020

In industries ranging from pharmaceuticals to fine chemicals, there is a need to take small, labora…

Improving the luck of the horseshoe crab

Added: 21 Sep 2020

Following some recent media controversy, Allen Burgenson, and Glenn Gauvry update our original July…

Big data for understanding small molecules; a case study

Added: 25 Aug 2020

As big data continues to transform the industry must we remain so reluctant to share data? In her a…

Collaborate to accumulate

Added: 25 Aug 2020

Pharmaceutical research and development has historically been shrouded in mystery; a secretive acti…

The great vaccine paradox

Added: 3 Aug 2020

by Dermot Martin

What happens if the best defence against a virus develops an image problem? As we…

GSK partners CRISPR discoverer to develop rapid COVID-19 test

Added: 5 Jun 2020

Gene editor turns gene detective: Dermot Martin investigates a successful COVID-19 test development…

Re-purposing familiar drugs to defend against COVID 19

Sarah Lawton | Added: 15 May 2020

By Dermot Martin

Drugs with a successful track record against rare diseases occasionally show posi…

What’s your poison?

Sarah Lawton | Added: 11 May 2020

Why are so many drugs derived from natural sources on the market to treat human disease? Venom-mast…

Going (anti)viral

Added: 28 Apr 2020

Dermot Martin catches us up with the rapid reaction of the biopharma community to meet the Covid-19…

Going round in circles

Added: 9 Apr 2020

Single use plastics are a staple in the lab – but they are also are part of the plastics pollution …

Coronavirus – is it just “a type of ‘flu”?

Added: 2 Apr 2020

The virology, genomics, epidemiology and medical response – Chief Virology Examiner at the Institut…

Shining a light on diabetes

Added: 17 Mar 2020

The complexity of glycogen storage diseases like diabetes means a reductionist approach just won’t …

Does gene therapy put safety second?

Added: 15 Mar 2020

The delivery of gene therapies relies almost entirely on viral vectors. So, when it comes to the pr…

A certain ratio

Added: 27 Jan 2020

Has CRISPR just given us the ability to change the sex ratio in mammals? Dermot Martin reports on n…

Can we afford to cure the incurable?

Added: 14 Jan 2020

Putting us on the very cusp of a medical revolution – gene therapy could cure the incurable. But as…

Moving from push to pull

Added: 9 Dec 2019

Nothing less than an entirely new model of drug development is needed if we are to create new antib…